Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Purple Biotech Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q4 2022
- Shares held
- 125.2K
- −48.5K (−27.9%) vs. Q4 2022
- Total value
- $224.2K
- −$14.3K (−6.0%) vs. Q4 2022
- New holders
- 5
- 1 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 108 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $90 | 0.00% | +50 | New |
| North Star Investment Management Corp. | 300 | $537 | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 1,000 | $1.90K | 0.00% | +1,000 | New |
| Advisory Services Network, LLC | 1,995 | $3.57K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 2,600 | $4.65K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,371 | $5.93K | 0.00% | −830−19.8% | Reduced |
| UBS Group AG | 4,566 | $8.17K | 0.00% | −3,723−44.9% | Reduced |
| TD Waterhouse Canada Inc. | 4,000 | $9.58K | 0.00% | +4,000 | New |
| Raymond James & Associates | 11,000 | $19.7K | 0.00% | +11,000 | New |
| Geode Capital Management, LLC | 12,666 | $22.3K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 12,505 | $22.4K | 0.02% | 00.0% | Unchanged |
| Venture Visionary Partners LLC | 13,068 | $23.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 15,175 | $26.7K | 0.00% | −30,690−66.9% | Reduced |
| Simplex Trading, LLC | 19,703 | $34.0K | 0.00% | +19,703 | New |
| Morgan Stanley | 23,088 | $41.3K | 0.00% | +1,218+5.6% | Added |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −14,719−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |